North East Medical JournalNorth East Medical JournalNorth East Medical Journal
  • Home
  • Manuscript preparation
  • Editorial Board
  • Current Issue
  • Publication Submission
  • Publications
  • NEMC Site
Font ResizerAa
North East Medical JournalNorth East Medical Journal
Font ResizerAa
  • Volume 14, No 2, July 2024
  • Home
  • Manuscript preparation
  • Editorial Board
  • Current Issue
  • Publication Submission
  • Publications
  • NEMC Site
Follow US
North East Medical Journal > Publications > Volume 14, No 2, July 2024 > Assessment of Efficacy of Terbinafine in The Treatment of Resistant Dermatophytosis
Volume 14, No 2, July 2024

Assessment of Efficacy of Terbinafine in The Treatment of Resistant Dermatophytosis

Iqbal AhmedParimol Kishore DevNadia TasnimShahria Raquib LizaSmita Roy
Published On : July 1, 2024 10:00 am

DOI : https://doi.org/10.64203/nemj/VUSD5972

By Iqbal Ahmed Parimol Kishore Dev Nadia Tasnim Shahria Raquib Liza Smita Roy
Share
2 Min Read
SHARE
Iqbal Ahmed1, Parimol Kishore Dev2, Nadia Tasnim3, Shahria Raquib Liza4, Smita Roy5
1. Assistant professor, Department of Dermatology and Venereology, Jalalabad Ragib Rabeya Medical College and Hospital, Sylhet
2. Associate professor, Department of Anaesthesia, Jalalabad Ragib Rabeya Medical College Hospital, Sylhet.
3. Registrar, Department of Dermatology and Venereology, Jalalabad Ragib Rabeya Medical College and Hospital, Sylhet
4. Assistant Registrar, Department of Dermatology and Venereology, Jalalabad Ragib Rabeya Medical College and Hospital, Sylhet
5. Assistant professor, Department of Biochemistry, North East Medical College Hospital, Sylhet
Abstract
The term “dermatophytosis” refers to a group of pathogenic fungi called dermatophytes that have a strong affinity for the keratinized tissues found in nails, skin, and hair. There are already a number of antifungal medications available to treat mycoses, yet they have limited cellular targets, and fungus may develop tolerance or resistance to them. An experimental study was conducted at the Jalalabad Ragib Rabeya Medical College and Hospital (JRRMCH) at Sylhet’s Department of Dermatology and Venereology. In total, 100 individuals with resistant dermatophytosis of all sorts participated in this study. Between 18 and 60 years old, patients of both sexes were included. Oral terbinafine 250 mg was administered to each patient twice daily. After three weeks, patients were recommended to follow up. A 51-75% improvement was seen in 45% of patients, while a 76-100% improvement was seen in 30% of patients. Only a small number of patients developed adverse effects (39%). According to our study. treating individuals with resistant dermatophytosis with oral terbinafine in a dose of 250 mg given twice daily was effective and safe.
Key Words: dermatophytosis, dermatophytes, resistance, terbinafine, efficacy, fungus

Request For Pdf Version of this Journal

Please enable JavaScript in your browser to complete this form.
Name *
Loading
Share This Article
Facebook Twitter Copy Link Print
By Iqbal Ahmed
Assistant professor, Department of Dermatology and Venereology, Jalalabad Ragib Rabeya Medical College and Hospital, Sylhet
By Parimol Kishore Dev
Assistant Professor, Department of Anesthesia, Jalalabad Ragib Rabeya Medical College, Sylhet
By Nadia Tasnim
Register, Department of Dermatology, Jalalabad Ragib-Rabeya Medical College.
By Shahria Raquib Liza
Assistant Registrar, Department of Dermatology and Venereology, Jalalabad Ragib Rabeya Medical College and Hospital, Sylhet
By Smita Roy
Assistant Professor, Department of Biochemistry, North East Medical College, Sylhet
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Publications

  • Isolated Epididymal Tuberculosis in an Adolescent: A case report November 4, 2026
  • Anthropometric Study of Lower Limb Length of Male Bangladeshi Rickshaw Pullers November 4, 2026
  • “Patient Profile and Treatment Outcome of Colorectal Cancer Patients Treated with Multimodality Therapy at A Regional Cancer Center at Sylhet, Bangladesh.” November 4, 2026
  • Risk Factors of Neonatal Thrombocytopenia-A Prospective Observational Study November 4, 2026
  • Pathological Characteristics of Suspected Lung Lesions on CT guided FNAC: A Hospital Based Retrospective Study November 4, 2026

You Might Also Like

Volume 14, No 2, July 2024

Molecular Response Status of Chronic Myeloid Leukemia (CML) Patients on Regular Tyrosine Kinase Inhibitor (TKI) Therapy: A Cross-Sectional Study

By Abu Yousuf Md. Nazim Uddin Mohiuddin A Khan Salma Afrose Akhil R Biswas Tasneem Ara Mafruha Akhter Alamgir Ahmed Tanzil Sajjad
Volume 14, No 2, July 2024

The Impact of Dyslipidemia on Glycemic Control in Type 2 Diabetes Patients: A Hospital Based Study

By Smita Roy Parimol Kishore Dev Begum Nazmus Sama Shimu Nasrin Akter Chowdhury Mushfika Rahman Umme Asma Mridha Syeda Umme Fahmida Malik Saleha Afrin Bristi
Volume 14, No 2, July 2024

Challenges for Fistula (First Approach) for Maintenance Hemodialysis among the Dialysis patients of Sylhet Division in Bangladesh

By Abdul Latif Shubharthi Kar Abu Ahmed Golam Akbar Minhaz Nizam Uddin Rajendra Prasad Das
Volume 14, No 2, July 2024

Clinically Severe Covid-19 Patients: How Do Laboratory Investigations Correlate Physicians’ Assessment?

By Fazle Elahi Nurani Muhammad Arif-un Nabi Estiak Ahmed

The North East Medical Journal (NEMJ) website serves as a comprehensive platform for managing and disseminating scholarly medical articles.

Social Links
Facebook Twitter Youtube Instagram

© All Rights Reserved By North East Medical Journal.

Developed By :IT Lab Solutions Ltd.

Welcome Back!

Sign in to your account

Lost your password?